The potential of ginsenosides for anti-tumor therapy comes from its diverse anti-tumor mechanisms against multiple hallmarks of cancer, among which TP53 and IL-6 as well as associated biological processes and signaling pathways may be the key points to comprehending the anti-tumor mechanism of ginsenosides. This evidence concerns the gene TP53 and neoplasm.